Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development

Dyadic International, Inc. today announced collaboration with Jiangsu Hengrui Medicine Co., Ltd. ("Hengrui") (SSE:600276) to apply Dyadic's C1 technology to the development of selected Hengrui biologic drug(s).